Ligand source activities (1 row/activity)





Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Potency)
# tested GPCRs
(Potency)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
1499 8872 47 None -63 38 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assayAgonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C nan
3779 8872 47 None -63 38 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assayAgonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C nan
536 8872 47 None -63 38 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assayAgonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C nan
CHEMBL434 8872 47 None -63 38 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assayAgonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C nan
DB01064 8872 47 None -63 38 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assayAgonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C nan
1499 8872 47 None -63 38 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assayAgonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
3779 8872 47 None -63 38 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assayAgonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
536 8872 47 None -63 38 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assayAgonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
CHEMBL434 8872 47 None -63 38 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assayAgonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
DB01064 8872 47 None -63 38 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assayAgonist activity at human TAS2R43 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay
Drug Central 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C None
12460 7041 0 None -1 2 Human 2.5 pEC50 = 2.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 163 0 1 4 -0.7 CC1=CC(=O)NS(=O)(=O)O1 15537898
36573 7041 0 None -1 2 Human 2.5 pEC50 = 2.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 163 0 1 4 -0.7 CC1=CC(=O)NS(=O)(=O)O1 15537898
CHEMBL176687 7041 0 None -1 2 Human 2.5 pEC50 = 2.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 163 0 1 4 -0.7 CC1=CC(=O)NS(=O)(=O)O1 15537898
5143 10230 0 None -1 2 Human 2.8 pEC50 = 2.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 183 0 1 3 0.1 O=C1NS(=O)(=O)c2c1cccc2 15537898
5432 10230 0 None -1 2 Human 2.8 pEC50 = 2.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 183 0 1 3 0.1 O=C1NS(=O)(=O)c2c1cccc2 15537898
CHEMBL310671 10230 0 None -1 2 Human 2.8 pEC50 = 2.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 183 0 1 3 0.1 O=C1NS(=O)(=O)c2c1cccc2 15537898
115149 7178 0 None -186 3 Human 4.1 pEC50 = 4.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 586 7 6 13 1.1 C=C[C@@H]1[C@@H]2CCOC(=O)C2=CO[C@H]1O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)OC(=O)C4=C(C=C(C=C4O)O)C5=CC(=CC=C5)O 20022913
12459 7178 0 None -186 3 Human 4.1 pEC50 = 4.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 586 7 6 13 1.1 C=C[C@@H]1[C@@H]2CCOC(=O)C2=CO[C@H]1O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)OC(=O)C4=C(C=C(C=C4O)O)C5=CC(=CC=C5)O 20022913
12468 8645 0 None -1 2 Human 5.2 pEC50 = 5.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 262 0 1 4 1.2 C[C@H]1[C@H]2[C@@H](CC1=O)C(=C)C[C@@H]([C@@H]3[C@@H]2OC(=O)C3=C)O 26406243
442256 8645 0 None -1 2 Human 5.2 pEC50 = 5.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 262 0 1 4 1.2 C[C@H]1[C@H]2[C@@H](CC1=O)C(=C)C[C@@H]([C@@H]3[C@@H]2OC(=O)C3=C)O 26406243
CHEMBL271958 8645 0 None -1 2 Human 5.2 pEC50 = 5.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 262 0 1 4 1.2 C[C@H]1[C@H]2[C@@H](CC1=O)C(=C)C[C@@H]([C@@H]3[C@@H]2OC(=O)C3=C)O 26406243
102129367 7382 0 None 3 2 Human 5.4 pEC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 330 1 1 4 2.6 C[C@@]12CC(=O)C3=C([C@H]1CC[C@]45[C@H]2[C@@H]6C[C@H](C4)[C@@](C5)(O6)CO)CCO3 32437139
12469 7382 0 None 3 2 Human 5.4 pEC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 330 1 1 4 2.6 C[C@@]12CC(=O)C3=C([C@H]1CC[C@]45[C@H]2[C@@H]6C[C@H](C4)[C@@](C5)(O6)CO)CCO3 32437139
12467 8067 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 35364812
12498 7142 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 418 3 7 9 -0.9 C1=CC2=C(C(=C1)O)C(=O)C3=C(C2[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)C=C(C=C3O)CO 17702579
9866696 7142 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 418 3 7 9 -0.9 C1=CC2=C(C(=C1)O)C(=O)C3=C(C2[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)C=C(C=C3O)CO 17702579
CHEMBL497001 7142 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 418 3 7 9 -0.9 C1=CC2=C(C(=C1)O)C(=O)C3=C(C2[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)C=C(C=C3O)CO 17702579
DB15477 7142 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 418 3 7 9 -0.9 C1=CC2=C(C(=C1)O)C(=O)C3=C(C2[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)C=C(C=C3O)CO 17702579
12499 9049 0 None -1 2 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 410 4 2 7 1.8 CC1=C2[C@@H]([C@@H]3[C@@H]([C@H](C1)OC(=O)CC4=CC=C(C=C4)O)C(=C)C(=O)O3)C(=CC2=O)CO 36601079
174880 9049 0 None -1 2 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 410 4 2 7 1.8 CC1=C2[C@@H]([C@@H]3[C@@H]([C@H](C1)OC(=O)CC4=CC=C(C=C4)O)C(=C)C(=O)O3)C(=CC2=O)CO 36601079
12438 7259 0 None 5 3 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 341 3 1 6 3.3 COC1=CC=CC2=C3C(=C(C=C21)[N+](=O)[O-])C(=CC4=C3OCO4)C(=O)O 15537898
2236 7259 0 None 5 3 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 341 3 1 6 3.3 COC1=CC=CC2=C3C(=C(C=C21)[N+](=O)[O-])C(=CC4=C3OCO4)C(=O)O 15537898
CHEMBL93353 7259 0 None 5 3 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 341 3 1 6 3.3 COC1=CC=CC2=C3C(=C(C=C21)[N+](=O)[O-])C(=CC4=C3OCO4)C(=O)O 15537898
12470 8059 0 None 3 2 Human 2.3 pIC50 = 2.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 179 2 2 2 0.7 C1CCC(CC1)NS(=O)(=O)O 28919036
7533 8059 0 None 3 2 Human 2.3 pIC50 = 2.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 179 2 2 2 0.7 C1CCC(CC1)NS(=O)(=O)O 28919036
CHEMBL1206440 8059 0 None 3 2 Human 2.3 pIC50 = 2.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 179 2 2 2 0.7 C1CCC(CC1)NS(=O)(=O)O 28919036
6300 7732 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 154 5 0 1 3.0 O=CCC(CCC=C(C)C)C 27569025
7794 7732 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 154 5 0 1 3.0 O=CCC(CCC=C(C)C)C 27569025
12471 6894 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 114 4 0 1 2.0 CCCC(C)CC=O 27569025
140511 6894 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 114 4 0 1 2.0 CCCC(C)CC=O 27569025
25099817 8583 0 None -3 3 Human 5.0 pIC50 = 5.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 198 4 1 1 3.3 CC1CCC(C1(C)C)CCCC(=O)O 20537538
9112 8583 0 None -3 3 Human 5.0 pIC50 = 5.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 198 4 1 1 3.3 CC1CCC(C1(C)C)CCCC(=O)O 20537538




Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Affinity)
# tested GPCRs
(Affinity)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI